The mission of the Amanda Mann Clark Project is to increase awareness of early onset colorectal cancer, fight for access to preventative screenings, promote available support for patients and families, and to inspire efforts in funding critical research.
Bright Spot Network is a national nonprofit that supports caregivers who are parenting small children (0-6 years old) while navigating their own cancer diagnosis. We host support groups, offer financial grants, give away free age-appropriate books on cancer, and more.
The Colon Cancer Coalition is dedicated to encouraging screening and raising awareness of colorectal cancer. CCC provides support to local communities to build and sustain programs and research encouraging early prevention, screening, and patient support for this disease.
The Global Colon Cancer Association advocates for equitable access to quality colorectal cancer screenings, testing, treatments, and care.
GCCA works toward this goal by amplifying and supporting the efforts of our member organizations, by developing adaptable advocacy and educational materials for our members, and by conducting our own advocacy, education, and initiatives that ensure patients are at the heart of all policy discussions.
Man Up to Cancer inspires men to connect and avoid isolation during our cancer journeys.
Founded in 2020 by stage IV colon cancer survivor Trevor Maxwell, Man Up to Cancer is a purpose-driven company and online community. We offer a podcast, website, social media channels, and an insanely engaged Facebook group called The Howling Place.
When faced with cancer, women tend to “reach out,” and men tend to “check out.” This leads men down the path toward mental health problems, strained relationships, and poor medical outcomes. It’s time for a new path.
We are changing what it means to “Man Up” in the face of cancer. It’s not just about being tough. It means having the courage to accept help, and knowing we are smarter and stronger as a pack than we are as lone wolves.
The Patient Empowerment Network works to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome.
PEN’s programs enhance patient health literacy to enable shared decision-making and provide informational and educational resources to empower patients and care partners at every step of their cancer journey. PALTOWN is pleased to partner with PEN via their digital sherpa™ program.
Triage Cancer provides free education on the legal and practical issues that may impact individuals diagnosed with cancer and their caregivers.
Triage Cancer’s resources include webinars on topics like health and disability insurance, employment rights, and estate planning. They provide Quick Guides and Checklists on a wide range of topics from Medicare to legal assistance and much more.
Bayer is a Life Science company with a more than 150 year history. Bayer believes the convergence of biology and data science will be a key element for innovation in Pharmaceuticals. Digital technologies can transform the way health care is delivered, while cell and gene therapy has the potential to cure severe diseases.
Taiho Oncology has established a world class clinical development organization that works urgently to develop innovative cancer treatments. Taiho Oncology has an oral oncology pipeline consisting of selectively targeted agents.
Thermo Fisher Scientific provides scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry.
Veracyte is a global diagnostics company. Veracyte’s tests leverage innovations in genomic technology and machine learning to enable more confident diagnostic, prognostic and treatment decisions in challenging diseases such as lung cancer, prostate and bladder cancers, thyroid cancer, breast cancer, colon cancer and idiopathic pulmonary fibrosis.